Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Small Cell Lung Cancer (SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02409108
What this trial is testing

Perfusion-Induced Hyperthermia for Metastatic Carcinoma

Who this might be right for
Metastatic Non-Small Cell Lung CarcinomaSolid Tumor, Adult
Jonathan Kiev 4
Early research (Phase 1)UnknownNCT00006347
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Large-scale testing (Phase 3)Study completedNCT00006349
What this trial is testing

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer

Who this might be right for
Cognitive/Functional EffectsDeliriumDepression+2 more
Alliance for Clinical Trials in Oncology 9
Testing effectiveness (Phase 2)Ended earlyNCT01266018
What this trial is testing

Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ludwig Institute for Cancer Research 22
Large-scale testing (Phase 3)UnknownNCT00465491
What this trial is testing

Study of Picoplatin Efficacy After Relapse

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 399
Testing effectiveness (Phase 2)Study completedNCT00412880
What this trial is testing

BI 2536 Second Line Monotherapy in SCLC

Who this might be right for
Carcinoma, Small Cell
Boehringer Ingelheim 23
Testing effectiveness (Phase 2)Study completedNCT05898763
What this trial is testing

TEIPP Immunotherapy in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Erasmus Medical Center 26
Early research (Phase 1)Ended earlyNCT01212887
What this trial is testing

Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+4 more
Cancer Research UK 14
Testing effectiveness (Phase 2)Study completedNCT01137968
What this trial is testing

Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Geron Corporation 116
Testing effectiveness (Phase 2)UnknownNCT04698941
What this trial is testing

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Study completedNCT00004186
What this trial is testing

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 55
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT02258607
What this trial is testing

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Who this might be right for
Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
Sierra Oncology LLC - a GSK company 21
Early research (Phase 1)Study completedNCT00084799
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

Who this might be right for
Lung Cancer
Ludwig Institute for Cancer Research 10
Early research (Phase 1)Study completedNCT01079481
What this trial is testing

Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Samsung Medical Center 21
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00003666
What this trial is testing

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 36
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Looking for participantsNCT02889666
What this trial is testing

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung Cancer
Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450
What this trial is testing

Dupilumab_Metastatic NSCLC

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Thomas Marron 33
Next Page